Replication Study: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

Steven Pelech, Curtis Gallagher, Catherine Sutter, Lambert Yue, John Kerwin, Ajay Bhargava, Elizabeth Iorns, Rachel Tsui, Alexandria Denis, Nicole Perfito, Timothy M. Errington

2021. DOI 10.1101/2021.11.30.470372

Has this study been replicated?

This paper is itself a replication attempt. The study it set out to replicate is listed below.

Study replicated

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth, Hatzivassiliou et al. (2010). Nature. View paper

Cite this record

Pelech, S., Gallagher, C., Sutter, C., Yue, L., Kerwin, J., Bhargava, A., Iorns, E., Tsui, R., Denis, A., Perfito, N., & Errington, T. M. (2021). Replication Study: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. https://doi.org/10.1101/2021.11.30.470372

Other studies in the atlas

Failed replications · Successful replications · All browse pages